HRQoL Keratinocyte Carcinomas

Enrolling by invitationOBSERVATIONAL
Enrollment

2,400

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Basal Cell CarcinomaSquamous Cell CarcinomaActinic Keratoses
Interventions
OTHER

questionnaires

EQ-5D-5L questionnaire questioning their overall health on five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). In addition patients will have to fill in the generic 15D questioning 15 specific dimensions on 5 levels as well as the BaSQoL, which is a disease specific questionnaire for patients with KC. The Time-trade off task is the final question.

Trial Locations (2)

9000

Department of Dermatology, Ghent University Hospital, Ghent

Unknown

MC Rotterdam Department of Dermatology, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

University Hospital, Ghent

OTHER